Advances in Ocular Drug Delivery

Ocular drug delivery was a milestone to pharmacologists  due to eye's unique anatomy and physiology. The clinical demand arises for the delivery of therapeutic molecules in the anterior and posterior parts of the eye. Conventional eye drops are used for the treatment of ocular low corneal penetration but has poor ocular bioavailability (∼5%). Hence biopolymers are preferred for the composite materials that  enhances the precorneal retention time, drug delivery control and induces the corneal absorption of drugs.
  • Track 1-1 Pharmacosomes
  • Track 2-2 Scleral Buckling Materials
  • Track 3-3 Retrometabolic delivery system
  • Track 4-4 Lacrisert
  • Track 5-5 Capsular type

Related Conference of Ophthalmology